Created at Source Raw Value Validated value
June 8, 2022, 3:30 p.m. usa

Incidence of adverse events leading to withdrawal;Neutralizing antibody level against SARS-CoV-2 GMT;Neutralizing antibody level against SARS-CoV-2 IgG antibody GMC;Neutralizing antibody level against SARS-CoV-2 Positive conversion rate;Neutralizing antibody level against SARS-CoV-2 positive rate;Severity of adverse events leading to withdrawal;the incidence of abnormal blood biochemistry, blood routine, blood coagulation function and urine routine;The incidence of AESI observed;The incidence of SAE observed;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events

Incidence of adverse events leading to withdrawal;Neutralizing antibody level against SARS-CoV-2 GMT;Neutralizing antibody level against SARS-CoV-2 IgG antibody GMC;Neutralizing antibody level against SARS-CoV-2 Positive conversion rate;Neutralizing antibody level against SARS-CoV-2 positive rate;Severity of adverse events leading to withdrawal;the incidence of abnormal blood biochemistry, blood routine, blood coagulation function and urine routine;The incidence of AESI observed;The incidence of SAE observed;The incidence rate of any adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence rate of solicited adverse reactions/events;The incidence severity of any adverse reactions/events;The incidence severity of solicited adverse reactions/events;The incidence severity of solicited adverse reactions/events